More importantly, the multivariate analysis confirmed that increased ZFPM2-AS1 expression was an independent unfavorable prognostic factor for HCC patients (HR = 2.834, 95% CI: 1.271–4.278, p = 0.013, Table 2). This evidence concerns the gene ZFPM2 and hepatocellular carcinoma.